SABS
SAB Biotherapeutics Inc
3.20$
+0.2%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | -80.1% | -1,280.7% | – | – | – | |
| – | +69.5% | +201.7% | +99.1% | +13.8% | +28.0% | -35.7% | |
| – | +248.8% | +78.7% | +15.5% | -9.4% | +21.4% | +77.1% | |
| – | +247.8% | +348.1% | -233.6% | – | – | – | |
| – | – | – | -102.0% | – | -198.8% | – | |
| – | +1,991.5% | -14.0% | -80.2% | -90.9% | +71.1% | +176.7% | |
| – | +1,990.0% | -14.0% | -80.9% | -92.7% | +7,733.6% | +917.4% | |
| – | – | – | -81,896.2% | -100.0% | – | – | |
| – | +47.3% | -75.2% | +350.6% | -61.9% | +132.3% | -53.9% | |
| – | +144.0% | +299.6% | -97.1% | +6,250.8% | -101.8% | – | |
| – | – | +330.0% | -191.0% | – | -214.8% | – | |
| – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.